These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


322 related items for PubMed ID: 15382115

  • 1. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.
    Nichols MT, Gidey E, Matzakos T, Dahl R, Stiegmann G, Shah RJ, Grantham JJ, Fitz JG, Doctor RB.
    Hepatology; 2004 Oct; 40(4):836-46. PubMed ID: 15382115
    [Abstract] [Full Text] [Related]

  • 2. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease.
    Wilson PD, Du J, Norman JT.
    Eur J Cell Biol; 1993 Jun; 61(1):131-8. PubMed ID: 8223698
    [Abstract] [Full Text] [Related]

  • 3. CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.
    Amura CR, Brodsky KS, Gitomer B, McFann K, Lazennec G, Nichols MT, Jani A, Schrier RW, Doctor RB.
    Am J Physiol Cell Physiol; 2008 Mar; 294(3):C786-96. PubMed ID: 18199703
    [Abstract] [Full Text] [Related]

  • 4. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia.
    Wang W, Mei C, Tang B, Zhao H, Xu C, Li Z, Shen X, Fu W, Dai B.
    Nephrol Dial Transplant; 2006 May; 21(5):1278-88. PubMed ID: 16421164
    [Abstract] [Full Text] [Related]

  • 5. VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
    Amura CR, Brodsky KS, Groff R, Gattone VH, Voelkel NF, Doctor RB.
    Am J Physiol Cell Physiol; 2007 Jul; 293(1):C419-28. PubMed ID: 17475663
    [Abstract] [Full Text] [Related]

  • 6. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
    Belibi FA, Reif G, Wallace DP, Yamaguchi T, Olsen L, Li H, Helmkamp GM, Grantham JJ.
    Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
    Elberg D, Jayaraman S, Turman MA, Elberg G.
    Exp Cell Res; 2012 Aug 01; 318(13):1508-16. PubMed ID: 22504005
    [Abstract] [Full Text] [Related]

  • 8. EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells.
    Elberg G, Elberg D, Lewis TV, Guruswamy S, Chen L, Logan CJ, Chan MD, Turman MA.
    Am J Physiol Renal Physiol; 2007 Nov 01; 293(5):F1622-32. PubMed ID: 17728378
    [Abstract] [Full Text] [Related]

  • 9. Liver cyst cytokines promote endothelial cell proliferation and development.
    Brodsky KS, McWilliams RR, Amura CR, Barry NP, Doctor RB.
    Exp Biol Med (Maywood); 2009 Oct 01; 234(10):1155-65. PubMed ID: 19596832
    [Abstract] [Full Text] [Related]

  • 10. Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia.
    Wilson PD, Hreniuk D, Gabow PA.
    J Cell Physiol; 1992 Feb 01; 150(2):360-9. PubMed ID: 1734038
    [Abstract] [Full Text] [Related]

  • 11. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease.
    Kanaan N, Goffin E, Pirson Y, Devuyst O, Hassoun Z.
    Am J Kidney Dis; 2010 May 01; 55(5):916-22. PubMed ID: 20189277
    [Abstract] [Full Text] [Related]

  • 12. Identifying cystogenic paracrine signaling molecules in cyst fluid of patients with polycystic kidney disease.
    Kenter AT, van Rossum-Fikkert SE, Salih M, Verhagen PCMS, van Leenders GJLH, Demmers JAA, Jansen G, Gribnau J, Zietse R, Hoorn EJ.
    Am J Physiol Renal Physiol; 2019 Jan 01; 316(1):F204-F213. PubMed ID: 30403162
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Basolateral chloride transporters in autosomal dominant polycystic kidney disease.
    Lebeau C, Hanaoka K, Moore-Hoon ML, Guggino WB, Beauwens R, Devuyst O.
    Pflugers Arch; 2002 Sep 01; 444(6):722-31. PubMed ID: 12355171
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
    Hoevenaren IA, Wester R, Schrier RW, McFann K, Doctor RB, Drenth JP, Everson GT.
    Liver Int; 2008 Feb 01; 28(2):264-70. PubMed ID: 17927714
    [Abstract] [Full Text] [Related]

  • 18. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks.
    Song X, Di Giovanni V, He N, Wang K, Ingram A, Rosenblum ND, Pei Y.
    Hum Mol Genet; 2009 Jul 01; 18(13):2328-43. PubMed ID: 19346236
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.